Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Document › Details

TxCell S.A.. (10/25/17). "Press Release: TxCell Renegotiates OCABSA Financing Option to Extend Cash Runway [Not for distribution in the United States of America, Canada, Australia and Japan]". Valbonne.

Organisations Organisation TxCell S.A. (Euronext Paris: TXCL)
  Organisation 2 Yorkville Advisors Global L.P.
  Group Yorkville Group (Group)
Products Product finance
  Product 2 T cell therapy
Index term Index term TxCell–Yorkville Group: credit, 201606– up to €20m convertible notes with €10m warrants with 1st drawdown of €5m in 2 tranches for next 12 months
Persons Person Flipo, Raphaël (TxCell 201509 CFO)
  Person 2 Boissel, Stéphane (TxCell 201504– CEO before Genclis + Transgene + Innate Pharma + Lazard)

Record changed: 2017-11-03


Picture [iito] – Putting Information into Context 600x102px

More documents for TxCell S.A. (Euronext Paris: TXCL)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 600x60px

» top